<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03948659</url>
  </required_header>
  <id_info>
    <org_study_id>CRC_GHN_2019_004</org_study_id>
    <nct_id>NCT03948659</nct_id>
  </id_info>
  <brief_title>Ventriculo-arterial Coupling in Cirrhotics</brief_title>
  <acronym>VACCI</acronym>
  <official_title>Non-invasive Assessment of Ventriculo Arterial Coupling Among Cirrhotics in Intensive Care Unit</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cirrhotic in intensive care unit have a very specific haemodynamic status. Cardiovascular&#xD;
      abnormalities in advanced liver cirrhosis are characterized by a hyperdynamic circulation&#xD;
      featuring increased heart rate and high cardiac output, concomitant with decreased systemic&#xD;
      vascular resistance. As liver cirrhosis progresses, cardiac dysfunction, known as cirrhotic&#xD;
      cardiomyopathy, is associated with prognosis of these patients.&#xD;
&#xD;
      Specifically, diastolic dysfunction has been more emphasized for estimating clinical outcome&#xD;
      in cirrhotic patients, whereas systolic dysfunction has limited prognostic implications in&#xD;
      hepatorenal syndrome patients.&#xD;
&#xD;
      However, in most cirrhotic patients, cardiac dysfunction is latent and only manifests under&#xD;
      stressful conditions because reduced ventricular contractility in these patients is masked by&#xD;
      pronounced arterial vasodilation and increased arterial compliance. Therefore, a&#xD;
      load-dependent index such as left ventricular ejection fraction is insensitive to detect&#xD;
      systolic cardiac impairment in the resting state in cirrhotic patients. Hence, a more&#xD;
      appropriate index is required to evaluate the integration of the ventricular and arterial&#xD;
      systems in cirrhotic cardiovascular disorders.&#xD;
&#xD;
      Interaction between the left ventricle and the arterial system has been explained on the&#xD;
      basis of end-systolic pressure-volume relation. Left ventricular end-systolic elastance&#xD;
      (Ees), as quantified by the ratio of end-systolic pressure to end-systolic volume, is an&#xD;
      index of the load-independent ventricular contractile state. Given this pressure-volume&#xD;
      relationship, effective arterial elastance (Ea) can be calculated by the ratio of&#xD;
      end-systolic pressure to stroke volume, indicating a net measure of arterial load. The ratio&#xD;
      of these values (Ea/Ees), designated ventriculo-arterial coupling (VAC), represents the&#xD;
      integrated interaction of the ventricular and arterial systems.&#xD;
&#xD;
      We can evaluate it with non-invasive echocardiographic method.&#xD;
&#xD;
      We analyse VAC among cirrhotic patients admitted in intensive care unit, with non-invasive&#xD;
      echographic method thanks to records made from August 2018 to April 2019.&#xD;
&#xD;
      Hypothesis: VAC decrease from the baseline value when mean arterial pressure is improved.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 30, 2018</start_date>
  <completion_date type="Actual">April 30, 2019</completion_date>
  <primary_completion_date type="Actual">April 30, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Ventriculo arterial coupling</measure>
    <time_frame>Ventriculo arterial coupling is estimated at T0 (before norepinephrine initiation) and every 6 hours during the first 24 hours.</time_frame>
    <description>The primary outcome is the non-invasive evaluation of ventriculo arterial coupling using a trans-thoracic echography</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">13</enrollment>
  <condition>Cirrhosis</condition>
  <arm_group>
    <arm_group_label>Cirrhotic patients in intensive care unit</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Arterio ventricular coupling</intervention_name>
    <description>We analyse ventriculo arterial coupling (VAC) among cirrhotic patients admitted in intensive care unit, with non-invasive echography method</description>
    <arm_group_label>Cirrhotic patients in intensive care unit</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Cirrhotic patients with acute decompensation admitted in intensive care unit and who&#xD;
        received norepinephrine as hemodynamic therapy&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Liver cirrhotic patients (any cause, any level)&#xD;
&#xD;
          -  With acute decompensation&#xD;
&#xD;
          -  Admitted in intensive care unit in Croix Rousse Hospital, Lyon, France&#xD;
&#xD;
          -  Who receive NOREPINEPHRINE as hemodynamic therapy&#xD;
&#xD;
          -  Blood pressure monitoring thanks to an arterial line (radial, humeral or femoral)&#xD;
&#xD;
          -  Urinary catheter, suprapubic catheter or any comparable device to monitor urine&#xD;
             output.&#xD;
&#xD;
          -  The patient did not object to take part of the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Acute hemorrhage (Clinical definition or hemoglobin lower than 70g/L at admission)&#xD;
&#xD;
          -  Patient requiring kidney replacement therapy&#xD;
&#xD;
          -  Patient requiring invasive mechanical ventilation&#xD;
&#xD;
          -  Any pathology that makes non-invasive ventriculo arterial coupling assessment&#xD;
             impossible (non-sinus rhythm, severe valvular disease)&#xD;
&#xD;
          -  Patient who objects to take part of the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hadrien Pambet</name>
      <address>
        <city>Lyon</city>
        <zip>69004</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2019</verification_date>
  <study_first_submitted>May 10, 2019</study_first_submitted>
  <study_first_submitted_qc>May 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 14, 2019</study_first_posted>
  <last_update_submitted>May 13, 2019</last_update_submitted>
  <last_update_submitted_qc>May 13, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 14, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibrosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

